MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202511003763 A) filed by Cellmed Biotech Pvt. Ltd on February 16, 2025, for Cell-Free Bioactive Component Formulation, Method For Preparation And A Delivery Platform For Multi-Format Administration.
Inventor includes Lalit Jaiswal.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present disclosure relates to a standardized, cell-free mesenchymal stem cell (MSC)-derived bioactive formulation, its method for preparation, and a format-specific delivery platform for veterinary applications. The formulation is derived from adipose tissue MSC secretome and comprises quantified growth factors, cyt...